Mineralocorticoid Receptor Antagonists in Central Serous Chorioretinopathy: A Meta-Analysis of Randomized Controlled Trials.

Wang, Sean K; Sun, Peng; Tandias, Rachel M; Seto, Brendan K; Arroyo, Jorge G

Wang, Sean K; Sun, Peng; Tandias, Rachel M; Seto, Brendan K; Arroyo, Jorge G.

Afiliação

Wang SK; Division of Ophthalmology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Sun P; Division of Ophthalmology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Department of Ophthalmology, First Hospital of China Medical University, Shenyang, People's Republic of China.
Tandias RM; Division of Ophthalmology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Seto BK; Division of Ophthalmology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Arroyo JG; Division of Ophthalmology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Electronic address: jarroyo@bidmc.harvard.edu.

Ophthalmol Retina ; 3(2): 154-160, 2019 02.

Article em En | MEDLINE | ID: mdl-31014765

Assuntos

Coriorretinopatia Serosa Central/tratamento farmacológico; Eplerenona/uso terapêutico; Antagonistas de Receptores de Mineralocorticoides/uso terapêutico; Espironolactona/uso terapêutico; Humanos; Ensaios Clínicos Controlados Aleatórios como Assunto; Acuidade Visual; Conduta Expectante

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espironolactona / Antagonistas de Receptores de Mineralocorticoides / Coriorretinopatia Serosa Central / Eplerenona Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Ophthalmol Retina Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google